Skip to main content
74°
Light Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nutriband Inc
(NQ:
NTRB
)
4.080
-0.170 (-4.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nutriband Inc
< Previous
1
2
3
4
Next >
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
July 21, 2022
ORLANDO, FL / ACCESSWIRE / July 21, 2022 / RedChip Companies will air a new interview with Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), on The RedChip Money Report® on Bloomberg TV, this Saturday, July...
From
RedChip
Via
AccessWire
Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares
July 15, 2022
ORLANDO, FL / ACCESSWIRE / July 15, 2022 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that it has received a verdict in favor of the company, where the company prevailed on all issues,...
From
Nutriband Inc.
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
June 03, 2022
New proposed guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)
May 27, 2022
ORLANDO, FL / ACCESSWIRE / May 27, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, contract research and development...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
May 20, 2022
Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the Emerging Growth Conference
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
May 17, 2022
ORLANDO, FL / ACCESSWIRE / May 17, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter of a million dollars in new in contract manufacturing orders through...
From
Nutriband Inc.
Via
AccessWire
Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
May 11, 2022
Class 1 Medical Device Registration Allows Nutriband To Explore New Product Manufacturing Opportunities Through Its Wholly Owned Subsidiary Active Intelligence LLC ORLANDO, FL / ACCESSWIRE / May 11,...
From
Nutriband Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
April 29, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice
February 16, 2022
ORLANDO, FL / ACCESSWIRE / February 16, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the United States Patent and Trademark Office (USPTO) has published its patent titled...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4
February 04, 2022
ORLANDO, FL / ACCESSWIRE / February 4, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) will be participating in the Benzinga ALL ACCESS, which will take place on February 4. Nutriband CEO, Gareth...
From
Nutriband Inc.
Via
AccessWire
Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office
January 28, 2022
ORLANDO, FL / ACCESSWIRE / January 28, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the receipt of an Issue Notification from the United States Patent and Trademark Office (USPTO)...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology
January 18, 2022
ORLANDO, FL / ACCESSWIRE / January 18, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced an expanded product development pipeline for its proprietary AVERSA™ abuse deterrent transdermal...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 10, 2022
ORLANDO, FL / ACCESSWIRE / January 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the signing of a feasibility agreement with Kindeva Drug Delivery to develop Nutriband's lead...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm
January 05, 2022
ORLANDO, FL / ACCESSWIRE / January 5, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products has completed the market assessment...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application
December 31, 2021
ORLANDO, FL / ACCESSWIRE / December 31, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the Korean Intellectual Property Office (KIPO) has fully issued its patent titled "Abuse...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Announces $1 Million Share Repurchase Authorization
December 29, 2021
ORLANDO, FL / ACCESSWIRE / December 29, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of December 29,...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services
December 21, 2021
ORLANDO, FL / ACCESSWIRE / December 21, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services,...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary
December 13, 2021
ORLANDO, FL / ACCESSWIRE / December 13, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services,...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021
December 03, 2021
ORLANDO, FL / ACCESSWIRE / December 3, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services,...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl
November 16, 2021
ORLANDO, FL / ACCESSWIRE / November 16, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services,...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
November 10, 2021
ORLANDO, FL / ACCESSWIRE / November 10, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M
October 22, 2021
ORLANDO, FL / ACCESSWIRE / October 22, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services,...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
October 12, 2021
ORLANDO, FL / ACCESSWIRE / October 12, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
WestPark Capital Announces Completion of a $6.6 Million Public Offering for Nutriband Inc. (NASDAQ: NTRB) and Up-listing to the NASDAQ Capital Market
October 05, 2021
From
WestPark Capital
Via
Business Wire
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
October 04, 2021
ORLANDO, FL / ACCESSWIRE / October 4, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market
October 01, 2021
ORLANDO, FL / ACCESSWIRE / October 1, 2021 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products focused on preventing opioid abuse, contract...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.